Scinai Immunotherapeutics (SCNI) EBITDA (2022 - 2023)
Scinai Immunotherapeutics (SCNI) EBITDA from Mar 31, 2022 to Mar 31, 2023. The TTM Scinai Immunotherapeutics (SCNI) EBITDA is -$3.05M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Scinai Immunotherapeutics (SCNI) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +22.98% |
Annual EBITDA change of Scinai Immunotherapeutics (SCNI)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$6.12M | -12.45% |
| 2024 | -$6.99M | -23.94% |
| 2023 | -$9.19M | -12.48% |
| 2022 | -$11M | +1.06% |
| 2021 | -$10M | N/A |
Comparison Scinai Immunotherapeutics (SCNI) five years EBITDA CAGR with competitors
Scinai Immunotherapeutics (SCNI) five years EBITDA CAGR is -10.04%.